dihexa solubility in dmso mg ml mg/ml Non-aqueous, zwitterionic solvent as an alternative for dimethyl sulfoxide the life sciences Dihexa is concentrated in multiple – DIHEXA 30ML LIQUID (20MG/ML, 600MG

With an estimated potency up to one million times greater than BDNF in promoting new synapses, Dihexa is positioned as one of the most promising compounds in neuroplasticity, memory and cognitive function research

Key Features Blend strength: BPC-157 10 mg + TB-500 10 mg per vial (20 mg total) Pack size: 10 vials/kit (bulk supply available on request) Format: lyophilized powder for stable storage and handling in lab workflows Supplier positioning: China-based factory supply with export-ready cartons and secure packing Documentation: batch labeling and order coordination support for repeat wholesale buyers Typical Research Focuses Recovery-support and tissue-repair pathway models (non-clinical, research settings) Mobility & training-load recovery study frameworks (protocol-based, lab handling required) Stack compatibility research and stability handling for lyophilized peptide formats General peptide handling, storage, and logistics workflows for distributors Packaging & Ordering Standard inner packing: 10-vial plastic trays with bubble wrap and foam protection Outer packing: export-ready cartons with insulation and protective materials suitable for international transit Flexible order quantities starting from 1 kit for sample evaluation

This injection is also utilized in the treatment of edema associated with brain tumors and certain cancers

5-Amino-1MQ is frequently misclassified as a peptide

BPC-157 is not FDA approved for any human therapeutic use

2012 Sep;41(5):547-52